AVENUE THERAPEUTICS, INC. (ATXI) Return on equity 2024–2025
AVENUE THERAPEUTICS, INC. (ATXI) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-158.8%FY2025 · since FY2024: -416.6% → -158.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -158.8% | +257.8 pp |
| FY2024 | -416.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ATXI financial trends
ATXI RevenueATXI Net incomeATXI Net marginATXI Gross profitATXI Gross marginATXI Operating incomeATXI Operating marginATXI Operating cash flowATXI Free cash flowATXI Capital expendituresATXI Stock buybacksATXI Dividends paidATXI Total assetsATXI Total liabilitiesATXI Shareholders’ equityATXI overview →